Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes?

被引:12
|
作者
Semenkovich, Tara R. [1 ]
Samson, Pamela P. [2 ]
Hudson, Jessica L. [3 ]
Subramanian, Melanie
Meyers, Bryan F.
Kozower, Benjamin D. [1 ]
Kreisel, Daniel [1 ]
Patterson, G. Alexander [1 ]
Robinson, Clifford G. [2 ]
Bradley, Jeffrey D. [2 ]
Puri, Varun [1 ]
机构
[1] Washington Univ, Div Cardiothorac Surg, Dept Surg, St Louis, MO 63110 USA
[2] Washington Univ, Dept Radiat Oncol, St Louis, MO 63110 USA
[3] Washington Univ, Dept Cardiothorac Surg, 660 S Euclid Ave,Campus Box 8234, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
PHASE-III TRIAL; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; SURGERY; CHEMOTHERAPY; RADIOTHERAPY;
D O I
10.1016/j.athoracsur.2018.09.064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Wide variation is seen in the dosage of preoperative induction radiation therapy for esophageal cancer. We investigated associations between outcomes after esophagectomy and dosage of induction radiation therapy. Methods. Patients undergoing induction radiation therapy (30 to 70 Gy), followed by esophagectomy, were identified from the National Cancer Database and classified as low (<40 Gy), standard (40 to 50.4 Gy), and high dose (>50.4 Gy). Perioperative outcomes and overall survival were compared. Subgroup analysis compared two common dosages: 45 Gy and 50.4 Gy. Results. From 2004 to 2014, 10,738 patients (84.7%) received standard-dose radiation, increasing from 69.7% in 2004 to 93.6% in 2014 (p < 0.001), 1,329 (10.5%) received low-dose radiation, and 608 (4.8%) received high-dose radiation. Higher rates of pathologic complete response (pCR; low: 11.7%, standard: 16.2%, high: 21.0%; p < 0.001) and downstaging (low: 52.0%, standard: 56.4%, high: 63.1%, p = 0.001) were observed as the dosage increased. On multivariable analysis, compared with standard-dose, high-dose radiation was associated with higher 30-day mortality (odds ratio [OR], 2.11; p < 0.001) without a higher likelihood of downstaging or pCR. Low-dose radiation was associated with lower likelihood of downstaging (OR, 0.85; p = 0.04) and pCR (OR, 0.67; p < 0.001) without lowering the risk of 30-day mortality. The dose of 50.4 Gy was associated with higher likelihood of pCR (OR, 1.12; p = 0.04), without affecting 30-day mortality, compared with 45 Gy. Conclusions. High-dose induction radiation (>50.4 Gy) is associated with increased perioperative death after esophagectomy, without a significant improvement in tumor response. Low-dose radiation (<30 Gy) is associated with worse tumor response without a lower risk of perioperative death. Within standard dosages, 50.4 Gy is associated with higher likelihood of pCR without adversely affecting perioperative mortality compared with 45 Gy. (C) 2019 by The Society of Thoracic Surgeons
引用
收藏
页码:903 / 911
页数:9
相关论文
共 50 条
  • [31] Radiation Therapy and Esophageal Cancer
    Shridhar, Ravi
    Almhanna, Khaldoun
    Meredith, Kenneth L.
    Biagioli, Matthew C.
    Chuong, Michael D.
    Cruz, Alex
    Hoffe, Sarah E.
    CANCER CONTROL, 2013, 20 (02) : 97 - 110
  • [32] Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer
    Zhan, Peter Lee
    Canavan, Maureen E.
    Ermer, Theresa
    Pichert, Matthew D.
    Li, Andrew X.
    Maduka, Richard C.
    Kaminski, Michael F.
    Johung, Kimberly L.
    Boffa, Daniel J.
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (12):
  • [33] Treatment outcomes of cervical esophageal cancer patients
    Kudou, Michihiro
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Konishi, Hirotaka
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Morimura, Ryo
    Murayama, Yasutoshi
    Komatsu, Shuhei
    Kuriu, Yoshiaki
    Ikoma, Hisashi
    Nakanishi, Masayoshi
    Ichikawa, Daisuke
    Okamoto, Kazuma
    Otsuji, Eigo
    ESOPHAGUS, 2016, 13 (04) : 323 - 329
  • [34] The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma
    Wong, Andrew T.
    Shao, Meng
    Rineer, Justin
    Lee, Anna
    Schwartz, David
    Schreiber, David
    ANNALS OF SURGERY, 2017, 265 (06) : 1146 - 1151
  • [35] Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer?
    Tessier, Williams
    Gronnier, Caroline
    Messager, Mathieu
    Hec, Flora
    Mirabel, Xavier
    Robb, William B.
    Piessen, Guillaume
    Mariette, Christophe
    ANNALS OF THORACIC SURGERY, 2014, 97 (04) : 1181 - 1190
  • [36] Outcomes in Locally Advanced Pancreatic Cancer After Induction Ablative Radiation Therapy and Resection
    Blair, Alex B.
    Jolissaint, Joshua S.
    Foster, Deshka
    Soares, Kevin C.
    Balachandran, Vinod P.
    Kingham, T. Peter
    Drebin, Jeffrey A.
    D'Angelica, Michael I.
    Jarnagin, William R.
    Crane, Christopher H.
    Reyngold, Marsha
    Wei, Alice C.
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 4108 - 4116
  • [37] The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer
    Wojcieszynski, Andrzej P.
    Berman, Abigail T.
    Wan, Fei
    Plastaras, John P.
    Metz, James M.
    Mitra, Nandita
    Apisarnthanarax, Smith
    CANCER, 2013, 119 (11) : 1976 - 1984
  • [38] Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival
    Haque, W.
    Verma, V.
    Butler, E. B.
    Teh, B. S.
    DISEASES OF THE ESOPHAGUS, 2019, 32 (04)
  • [39] A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer
    de Vos-Geelen, Judith
    Hoebers, Frank J. P.
    Geurts, Sandra M. E.
    Hoeben, Ann
    de Greef, Bianca T. A.
    Voncken, Francine E. M.
    Bogers, J. A.
    Braam, Petra M.
    Muijs, C. T.
    de Jong, Martin A.
    Kasperts, Nicolien
    Rozema, Tom
    Jeene, Paul M.
    Blom, Gerrit J.
    van Dieren, Jolanda M.
    Hulshof, Maarten C. C. M.
    van Laarhoven, Hanneke W. M.
    Grabsch, Heike, I
    Lemmens, Valery E. P. P.
    Tjan-Heijnen, Vivianne C. G.
    Nieuwenhuijzen, Grard A. P.
    ACTA ONCOLOGICA, 2020, 59 (08) : 895 - 903
  • [40] Intensity modulated radiation therapy in the treatment of esophageal cancer
    Yap, Johnny C.
    Malhotra, Harish K.
    Yang, Gary Y.
    THORACIC CANCER, 2010, 1 (02) : 62 - 69